Iodine 131 body scanning is a nuclear study performed to assist in diagnosing metastatic thyroid cancer anywhere in the body or in detecting extrathyroidal tissue or residual thyroid tissue after a total thyroidectomy. The radionuclide 131I as MIBG I 131 is administered orally, followed by scanning to reveal concentrations in the neck, lungs, or bones, indicating metastatic activity.
Nursing Care Before the Procedure
Client teaching and physical preparation are the same as for any nuclear scan study (see section under "Brain Scanning").
The client is given an oral dose of the radiopharmaceutical in a capsule and returned to or requested to return to the department 24 to 72 hours later. The client is then placed on the examining table in a supine position and requested to remain still while full body scanning is performed. Thyroid-stimulating hormone (TSH) can be administered IV before the radiopharmaceutical to stimulate any residual tissue to take up the radionuclide, if this is the reason for the study. A higher level of TSH also increases uptake by metastatic tumors.
Nursing Care After the Procedure
Care and assessment after the procedure are the same as for any nuclear scan study (see section under "Brain Scanning").